封面
市場調查報告書
商品編碼
1991468

全球羊膜市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Amniotic Membrane Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計羊膜市場將從 2025 年的 53.6 億美元成長到 2034 年的 167.3 億美元,2026 年至 2034 年的複合年成長率為 13.49%。

由於在再生醫學和創傷治療治療中的應用日益廣泛,全球羊膜市場正在成長。羊膜取自胎盤的子宮內膜,含有促進組織修復的生長因子和生物成分。這些羊膜廣泛應用於眼科、皮膚科和外科手術中,以促進傷口癒合和減輕發炎。

多種因素正在推動市場擴張。對先進創傷護理護理和再生醫學日益成長的需求,導致羊膜產品的使用量增加。醫療專業人員正在使用這些材料治療慢性傷口、燒燙傷和眼表疾病。此外,組織保存和處理技術的進步也提高了羊膜產品的安全性和有效性。

隨著再生醫學的進步,羊膜市場前景依然強勁。目前,人們正在探索這些生物材料在整形外科和重組外科領域的新應用。醫療保健投資的增加和醫學研究的拓展有望創造更多機會。隨著人們對生物來源治療方法的興趣日益濃厚,預計對羊膜產品的需求也將隨之成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球羊膜市場:依產品分類

  • 市場分析、洞察與預測
  • 冷凍保存的羊膜
  • 脫水羊膜

第5章:全球羊膜市場:依應用領域分類

  • 市場分析、洞察與預測
  • 外科性創傷
  • 眼科
  • 其他

第6章:全球羊膜市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 專科診所
  • 研究機構和學術機構

第7章 全球羊膜市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Alliqua BioMedical Inc
    • Amnio Technology LLC
    • Applied Biologics LLC
    • Human Regenerative Technologies LLC
    • DermaSciences
    • Katena Products Inc
    • MiMedx Group Inc
    • Skye Biologics Inc
    • Amniox Medical Inc
    • Organogensis Inc
簡介目錄
Product Code: VMR11214085

The Amniotic Membrane Market size is expected to reach USD 16.73 Billion in 2034 from USD 5.36 Billion (2025) growing at a CAGR of 13.49% during 2026-2034.

The global amniotic membrane market has grown due to its increasing use in regenerative medicine and wound healing treatments. Amniotic membranes, derived from the inner lining of the placenta, contain growth factors and biological components that promote tissue repair. These membranes are widely used in ophthalmology, dermatology, and surgical procedures to support healing and reduce inflammation.

Several factors are driving the market's expansion. The rising demand for advanced wound care treatments and regenerative therapies has increased the use of amniotic membrane products. Healthcare providers are using these materials in treatments for chronic wounds, burns, and eye surface disorders. Advances in tissue preservation and processing technologies have also improved the safety and effectiveness of amniotic membrane products.

The future outlook for the amniotic membrane market remains strong as regenerative medicine continues to advance. Research is exploring new medical applications for these biological materials in orthopedic and reconstructive procedures. Increasing healthcare investments and expanding medical research may create additional opportunities. As interest in biologically based therapies grows, the demand for amniotic membrane products is expected to increase.

MARKET SEGMENTATION

By Product

  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane

By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes and Academic Institutes

COMPANIES PROFILED

  • Alliqua BioMedical Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, DermaSciences, Katena Products Inc, MiMedx Group Inc, Skye Biologics Inc, Amniox Medical Inc, Organogensis Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AMNIOTIC MEMBRANE MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Cryopreserved Amniotic Membrane Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Dehydrated Amniotic Membrane Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AMNIOTIC MEMBRANE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Surgical Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AMNIOTIC MEMBRANE MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Research Institutes and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AMNIOTIC MEMBRANE MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AMNIOTIC MEMBRANE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Alliqua BioMedical Inc
    • 9.2.2 Amnio Technology LLC
    • 9.2.3 Applied Biologics LLC
    • 9.2.4 Human Regenerative Technologies LLC
    • 9.2.5 DermaSciences
    • 9.2.6 Katena Products Inc
    • 9.2.7 MiMedx Group Inc
    • 9.2.8 Skye Biologics Inc
    • 9.2.9 Amniox Medical Inc
    • 9.2.10 Organogensis Inc